Statement Of Cash Flows

StemCell Institute - Filing #7253194

Concept 2024-04-01 to
2025-03-31
As at
2025-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2023-03-31
Statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
605,375,000 JPY
442,264,000 JPY
Interest and dividends received
8,854,000 JPY
3,022,000 JPY
Income taxes paid
-144,974,000 JPY
-110,661,000 JPY
Interest paid
-1,569,000 JPY
JPY
Net cash provided by (used in) operating activities
467,685,000 JPY
334,625,000 JPY
Cash flows from operating activities
Cash flows from operating activities
Cash flows from facilities maintenance and investing activities
Purchase of property, plant and equipment
-477,795,000 JPY
-183,457,000 JPY
Purchase of investment securities
-330,002,000 JPY
-199,900,000 JPY
Proceeds from sale of investment securities
186,939,000 JPY
72,327,000 JPY
Other, net
796,000 JPY
24,238,000 JPY
Cash flows from investing activities
Net cash provided by (used in) investing activities
-259,084,000 JPY
-811,773,000 JPY
Cash flows from financing activities
Purchase of treasury shares
-94,038,000 JPY
JPY
Dividends paid
-255,832,000 JPY
JPY
Proceeds from long-term borrowings
510,000,000 JPY
JPY
Net cash provided by (used in) financing activities
146,704,000 JPY
-1,333,000 JPY
Repayments of long-term borrowings
-10,083,000 JPY
JPY
Net increase (decrease) in cash and cash equivalents
355,305,000 JPY
-478,480,000 JPY
Effect of exchange rate change on cash and cash equivalents
JPY
JPY
Cash and cash equivalents
3,200,846,000 JPY
2,845,540,000 JPY
3,324,021,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.